Furthermore, PFKFB3 can regulate the cell cycle progression of breast cancer cells by downregulating p27 through AKT phosphorylation, which affects ERα stability and modulates sensitivity to endocrine therapy42. This evidence concerns the gene PFKFB3 and breast carcinoma.